Select Page ::

Testosterone Replacement Therapy Market Scope and Price Analysis of Top Manufacturers Profiles 2020-2027 – Primo Journal

Posted on January 8, 2020 by Prof Baldwin

Global Testosterone Replacement Therapy Market Research Report will give its customers Full Analytical Research, that gives all in-out detailes about Key Players like company profile, product portfolio, capacity, price, cost and revenue for forecast period of 2020 2027. This Report gives full evaluation of Testosterone Replacement Therapy Market that containes Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.

This Testosterone Replacement Therapy Market Research makes clear explanation on How or Why this market will take growth hike on mentioned period. A specific data of perticular characteristic such as Type, Size, Application, and end-user have been scanned in this research report. There are the basic segments included in segmentation analysis which are outcomes of SWOT analysis and PESTEL analysis.

Download Sample PDF of Testosterone Replacement Therapy Market Report

AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals are some of the major organizations dominating the global market.

Key players in the Testosterone Replacement Therapy market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Testosterone Replacement Therapy Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customers requirements.

The report also makes some important proposals for a new project of Testosterone Replacement Therapy Market before evaluating its feasibility. Overall, the report covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Testosterone Replacement Therapy market. It offers facts related to the mergers, acquirement, partnerships, and joint venture activities widespread in the market.

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Testosterone Replacement Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

What Testosterone Replacement Therapy Market report offers:

Regions Covered in This Report

The complete knowledge of Testosterone Replacement Therapy Market is based on the latest industry news, opportunities and trends. Testosterone Replacement Therapy Market research report offers a clear insight about the influential factors that are expected to transform the global market in the near future. Both top-down and bottom-up approaches have been used to estimate and validate the market size of Testosterone Replacement Therapy market, to estimate the size of various other dependent submarkets in the overall market.

Remarkable Attributes of Testosterone Replacement Therapy Market Report:

Customisation of the Report-In case of any queries or customisation requirements please connect with our Experts by Clicking Here who will ensure that your requirements are met.

See the article here:
Testosterone Replacement Therapy Market Scope and Price Analysis of Top Manufacturers Profiles 2020-2027 - Primo Journal

Testosterone Replacement Therapy Market: Industry Growth Prospects & Trends Analysis by 2027 – Food & Beverage Herald

Posted on January 8, 2020 by Prof Baldwin

Testosterone Replacement Therapy Market report presents the worldwide market size (Value, Production and Consumption), splits the breakdown (data status 2014-2019 and 5 Forces forecast 2020 to 2027), by manufacturers, region, type and application. This Testosterone Replacement Therapy market report profiles major topmost manufactures operating ( AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals) in terms of analyse various attributes such asProduction, Consumption, Revenue, Gross Margin, Cost, Gross, Market Share, CAGR, and Market Influencing Factors of the Testosterone Replacement Therapy industry in USA, EU, China, India, Japan and other regions Besides, the report also covers Testosterone Replacement Therapy market segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

GetFREE Sample PDF (including full TOC, Tables and Figures)of Testosterone Replacement TherapyMarket @

Research Methodology

WordWide Market Reports follows a comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, WordWide Market Reports has access to a wide range of the regional andglobal reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the360 Degree Perspective i.e. from theSupply Side andDemand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, aTop-Down approach andBottom-Up approach is followed to arrive at ultimate research findings.

Key Target Audience of Testosterone Replacement Therapy Market: Manufacturers of Testosterone Replacement Therapy, Raw Material Suppliers, Market Research and Consulting Firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Testosterone Replacement Therapy.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Experts:https://www.worldwidemarketreports.com/speakanalyst/204548

There Are 11 Chapters To Deeply Display The Testosterone Replacement Therapy Market.

Chapter 1, is definition and segment of Testosterone Replacement Therapy; Chapter 2, is executive summary of Testosterone Replacement Therapy Market; Chapter 3, to explain the industry chain of Testosterone Replacement Therapy; Chapter 4, to show info and data comparison of Testosterone Replacement Therapy Players; Chapter 5, to show comparison of types; Chapter 6, to show comparison of applications; Chapter 7, to show comparison of regions and courtiers(or sub-regions); Chapter 8, to show competition and trade situation of Testosterone Replacement Therapy Market; Chapter 9, to forecast Testosterone Replacement Therapy market in the next years; Chapter 10, to show investment of Testosterone Replacement Therapy Market;

Key Questions Answered in the Testosterone Replacement Therapy Market Report:

What are the most recentAdvanced Technologies Adopted by Testosterone Replacement Therapy?

How are the recent trends affecting growth in the global Testosterone Replacement Therapy market?

What are theKey Strategies Used By Players And Service Providers that are expected to impact the growth of the Testosterone Replacement Therapy market?

What are theResources Available In Respective Regions that attract leading players in the Testosterone Replacement Therapy market?

What was theHistorical Value and what will be the forecast value of the Testosterone Replacement Therapy market?

Link:
Testosterone Replacement Therapy Market: Industry Growth Prospects & Trends Analysis by 2027 - Food & Beverage Herald

North America Hormone Replacement Therapy Market Expected to Generate a Value of US $4.7 Billion by 2024 – ResearchAndMarkets.com – Business Wire

Posted on January 19, 2020 by Prof Baldwin

DUBLIN--(BUSINESS WIRE)--The "North America Hormone Replacement Therapy Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The publisher expects the market to reach a value of US$ 4.7 Billion by 2024, registering a CAGR of 5.35% during 2019-2024.

The North America hormone replacement therapy market reached a value of US$ 3.5 Billion in 2018. Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.

North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.

Key Questions Answered in This Report:

Report Coverage:

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market

5.1 Market Performance

5.2 Market Breakup by Product

5.3 Market Breakup by Route of Administration

5.4 Market Breakup by Type of Disease

5.5 Market Breakup by Region

5.6 Market Forecast

6 North America Hormone Replacement Therapy Market

6.1 Market Performance

6.2 Market Forecast

7 North America Hormone Replacement Therapy Market: Breakup by Product

7.1 Estrogen Replacement Therapy

7.2 Human Growth Hormone Replacement Therapy

7.3 Thyroid Replacement Therapy

7.4 Testosterone Replacement Therapy

7.5 Others

8 North America Hormone Replacement Therapy Market: Breakup by Route of Administration

8.1 Oral

8.2 Parenteral

8.3 Transdermal

9 North America Hormone Replacement Therapy Market: Breakup by Type of Disease

9.1 Menopause

9.2 Hypothyroidism

9.3 Male Hypogonadism

9.4 Growth Hormone Deficiency

9.5 Others

10 North America Hormone Replacement Therapy Market: Breakup by Country

10.1 United States

10.1.1 Historical market Trends

10.1.2 Market Breakup by Product

10.1.3 Market Breakup by Route of Administration

10.1.4 Market Breakup by Type of Disease

10.1.5 Market Forecast

10.2 Canada

10.3 Mexico

11 SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Value Chain Analysis

12.1 Overview

12.2 Research and Development

12.3 Raw Material Procurement

12.4 Manufacturing

12.5 Marketing

12.6 Distribution

12.7 End-Use

13 Porter's Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Rivalry

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/xr45u2

Here is the original post:
North America Hormone Replacement Therapy Market Expected to Generate a Value of US $4.7 Billion by 2024 - ResearchAndMarkets.com - Business Wire

Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report – Kentucky Reports

Posted on December 2, 2019 by Prof Baldwin

The global market for testosterone replacement therapy is characterized by the presence of a large number of small and large scale manufacturers. All of the manufacturers have been steadfast in filling the meagre market gap in order to enhance their prospects of growth. Furthermore, research and development has been the central characteristic of al the market players operating in the global market. In 2015, it was found that 80% of the total market share was held by the top five market vendors with AbbVie Inc. taking the lead.

Obtain Report Details @https://www.transparencymarketresearch.com/testosterone-replacement-therapy.html

The large scale vendors are focusing on establishing an iconic brand for their product by resorting to rigorous marketing and advertising tactics. The smaller companies are expected to concentrate on capturing the local and regional markets to sustain themselves in the current scenario of stiff competition. A negative implication for the leading market players in recent times has been the loss of patents for their products. This has not only plundered them of revenues but has also affected the workflow of these companies.

The market players are expected to launch awareness campaigns about testosterone replacement therapies in order to educate and inform the consumers. Hence, the market for testosterone replacement therapies is expected to witness the emergence of several new trends and opportunities over the forthcoming years. Some of the key players in the global testosterone replacement therapy market include Bayer AG, Endo Pharmaceuticals, Inc., Novartis AG, and Allergen plc.

Request PDF Sample of Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

The CAGR for theglobal testosterone replacement therapy marketis estimated to be -4.20% over the period between 2016 and 2024. The negative growth rate of the global market is expected to take the market value from US2.0 bn in 2015 to a decreased value of US$1.3 bn by 2024-end.

High Incidence of Hypogonadism to Drive Market Demand

Research studies suggest that around 30% of all men suffer from testosterone deficiency, which has driven demand within the global market for testosterone replacement therapy. Furthermore, the population demographic of men in the age range of 40-79 years is more likely to suffer from testosterone deficiency. The need for mutation or having an offspring amongst men in the aforementioned age range has driven demand within the global market.

Moreover, the geriatric population has been on a rise, which underhandedly contributes to market growth. Several campaigns aimed at educating people about the benefits of testosterone replacement therapy have been an important propeller of demand within the global market. It is anticipated that more people suffering from testosterone deficiency would resort to these therapies over the coming years.

Enquiry for Discount on Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1097

Side Effects of Testosterone Replacement Therapy Could Obstruct Market Growth

Furthermore, the risk of developing cardiovascular diseases also discourages people from resorting to testosterone replacement therapies. The FDA has also cautioned people about the use of such therapies by issuing strict warnings, which has further obstructed the growth of the global market.

See the rest here:
Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report - Kentucky Reports

Testosterone Replacement Therapy Market Projections From 2020-2026 With Research Data on Consumption Analysis, Investment Cost, Profits Data and…

Posted on January 8, 2020 by Prof Baldwin

The global Testosterone Replacement Therapy market is broadly and deeply studied in the report with key focus on the competitive landscape, regional growth, market segmentation, and market dynamics. We have used latest primary and secondary research techniques for compiling this comprehensive research study. The report offers Porters Five Forces analysis, PESTLE analysis, competitive analysis, manufacturing cost analysis, revenue and production analysis, and various other types of analysis to provide a complete view of the global Testosterone Replacement Therapy market. Each segment of the global Testosterone Replacement Therapy market is carefully analyzed on the basis of market share, CAGR, and other vital factors. The global Testosterone Replacement Therapy market is also statistically presented with the help of Y-o-Y growth, CAGR, revenue, production, and other important calculations.

Get the Sample of this [emailprotected]https://www.qyresearch.com/sample-form/form/1433485/global-testosterone-replacement-therapy-market

We can customize the report as per your requirements. Our analysts are experts in market research and analysis and have a healthy experience in report customization after having served tons of clients to date. The main objective behind preparing the research study is to inform you about future market challenges and opportunities. The report is one of the best resources you could use to secure a strong position in the global Testosterone Replacement Therapy market.

Market Segmentation:

Following are the segments covered by the report are:GelsInjectionsPatchesOtherBy Application:HospitalsClinicsOthersKey Players:The Key manufacturers that are operating in the global Testosterone Replacement Therapy market are:AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Regional GrowthThe report offers in-depth analysis of key regional and country-level Testosterone Replacement Therapy markets, taking into account their market size, CAGR, market potential, future developments, and other significant parameters. The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Key Questions Answered What will be the size and CAGR of the global Testosterone Replacement Therapy market in 2025? Which product will gain the highest demand in the global Testosterone Replacement Therapy market? Which application could show the best growth in the global Testosterone Replacement Therapy market? What will be the nature of the competitive landscape in future? Which players will lead the global Testosterone Replacement Therapy market in the coming years? Which region will gain the largest share of the global Testosterone Replacement Therapy market?

Get Customized Report in your Inbox within 24 hours @https://www.qyresearch.com/customize-request/form/1433485/global-testosterone-replacement-therapy-market

Table of Contents

Report Overview: It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Testosterone Replacement Therapy market segments by application, study objectives, and years considered.

Global Growth Trends: There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.

Testosterone Replacement Therapy Market Share by Manufacturer: Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.

Market Size by Type: It includes analysis of price, production value market share, and production market share by type.

Market Size by Application: This section includes Testosterone Replacement Therapy market consumption analysis by application.

Profiles of Manufacturers: Here, leading players of the global market are studied based on sales area, key products, gross margin, revenue, price, and production.

Testosterone Replacement Therapy Market Value Chain and Sales Channel Analysis: It includes customer, distributor, Testosterone Replacement Therapy market value chain, and sales channel analysis.

Market Forecast Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

About Us:QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Continue reading here:
Testosterone Replacement Therapy Market Projections From 2020-2026 With Research Data on Consumption Analysis, Investment Cost, Profits Data and...

Testosterone Replacement Therapy Market : Global Competitive Analytics and Insights 2016 2024 – Downey Magazine

Posted on December 2, 2019 by Prof Baldwin

Furthermore, research and development has been the central characteristic of al the market players operating in the global market. In 2015, it was found that 80% of the total market share was held by the top five market vendors with AbbVie Inc. taking the lead. The large scale vendors are focusing on establishing an iconic brand for their product by resorting to rigorous marketing and advertising tactics. The smaller companies are expected to concentrate on capturing the local and regional markets to sustain themselves in the current scenario of stiff competition.

Obtain Report Details @https://www.transparencymarketresearch.com/testosterone-replacement-therapy.html

A negative implication for the leading market players in recent times has been the loss of patents for their products. This has not only plundered them of revenues but has also affected the workflow of these companies. The market players are expected to launch awareness campaigns about testosterone replacement therapies in order to educate and inform the consumers. Hence, the market for testosterone replacement therapies is expected to witness the emergence of several new trends and opportunities over the forthcoming years. Some of the key players in the global testosterone replacement therapy market include Bayer AG, Endo Pharmaceuticals, Inc., Novartis AG, and Allergen plc.

Request PDF Sample of Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

High Incidence of Hypogonadism to Drive Market Demand

Enquiry for Discount on Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1097

Side Effects of Testosterone Replacement Therapy Could Obstruct Market Growth

Despite the rising awareness amongst the masses about the advantages of testosterone replacement therapies, the market growth is hindered by the apprehension of the people. The chances of developing metabolic disorders are higher in men who undergo testosterone replacement therapies. Furthermore, the risk of developing cardiovascular diseases also discourages people from resorting to testosterone replacement therapies. The FDA has also cautioned people about the use of such therapies by issuing strict warnings, which has further obstructed the growth of the global market.

Read this article:
Testosterone Replacement Therapy Market : Global Competitive Analytics and Insights 2016 2024 - Downey Magazine

Testosterone Replacement Therapy Market To Witness Robust Expansion Throughout The Forecast Period 2019 2025 – Statsflash

Posted on December 2, 2019 by Prof Baldwin

Testosterone Replacement Therapy Market research report 2019 gives detailed information of major players like manufacturers, suppliers, distributors, traders, customers, investors and etc. Testosterone Replacement Therapy Market Report presents a professional and deep analysis on the present state of Testosterone Replacement Therapy Market that Includes major types, major applications, Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analysed in this report.

Get Exclusively Free Sample Of This Report in PDF @ https://dataintelo.com/request-sample/?reportId=51697

The growth trajectory of the Global Testosterone Replacement Therapy Market over the assessment period is shaped by several prevalent and emerging regional and global trends, a granular assessment of which is offered in the report. The study on analysing the global Testosterone Replacement Therapy Market dynamics takes a critical look at the business regulatory framework, technological advances in associated industries, and the strategic avenues.

Prominent Manufacturers in Testosterone Replacement Therapy Market includes * AbbVie* Allergan* Eli Lilly* Endo International* Acerus Pharmaceutical Corporation* Antares Pharma

Market Segment by Product Types * Gels* Injections* Patches* Other

Market Segment by Applications/End Users * Hospitals* Clinics* Others

Purchase the full version of this report at: https://dataintelo.com/checkout/?reportId=51697

In order to identify growth opportunities in the market, the report has been segmented into regions that are growing faster than the overall market. These regions have been potholed against the areas that have been showing a slower growth rate than the market over the global. Each geographic segment of the Testosterone Replacement Therapy Market has been independently surveyed along with pricing, distribution and demand data for geographic market notably: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

Additionally, the complete value chain and downstream and upstream essentials are scrutinized in this report. Essential trends like globalization, growth progress boost fragmentation regulation & ecological concerns. Factors in relation to products like the products prototype, manufacturing method, and R&D development stage are well-explained in the global Testosterone Replacement Therapy Market research report with point-to-point structure and with flowcharts. It offers a comparative study between conventional and emerging technologies and the importance of technical developments in this market. At last, the market landscape and its growth prospects over the coming years have been added in the research.

For Any Information About This Report, Visit https://dataintelo.com/enquiry-before-buying/?reportId=51697

The Questions Answered by Testosterone Replacement Therapy Market Report: What are the Key Manufacturers, raw material suppliers, equipment suppliers, end users, traders and distributors in Testosterone Replacement Therapy Market? What are Growth factors influencing Testosterone Replacement Therapy Market Growth? What are production processes, major issues, and solutions to mitigate the development risk? What is the Contribution from Regional Manufacturers? What are the Testosterone Replacement Therapy Market opportunities and threats faced by the vendors in the global Testosterone Replacement Therapy Industry? What are the Key Market segments, market potential, influential trends, and the challenges that the market is facing?And Many More

Ask For Discount On This Report At https://dataintelo.com/ask-for-discount/?reportId=51697

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry.Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataInteloName Alex MathewsEmail [emailprotected]Website https://dataintelo.comAddress 500 East E Street, Ontario, CA 91764, United States.

Link:
Testosterone Replacement Therapy Market To Witness Robust Expansion Throughout The Forecast Period 2019 2025 - Statsflash

Bragar Eagel & Squire, PC Reminds Investors That Class Action Lawsuits Have Been Filed Against Yunji, Plantronics, Lipocine, and Armstrong…

Posted on December 2, 2019 by Prof Baldwin

NEW YORK, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Yunji, Inc. (NASDAQ: YJ), Plantronics, Inc. (NYSE: PLT), Lipocine, Inc. (NASDAQ: LPCN), and Armstrong Flooring, Inc (NYSE: AFI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Yunji, Inc. (NASDAQ: YJ)

Class Period: Securities purchased pursuant and/or traceable to the registration statement and prospectus (collectively, the Registration Statement) issued in connection with the Companys May 2019 initial public offering (IPO or the Offering).

Lead Plaintiff Deadline: January 13, 2020

On May 3, 2019, the Company held its IPO in which it sold 11,217,447 shares for $11.00 per share.

On August 22, 2019, the Company disclosed a supply chain restructuring that shifted part of its merchandise sales to its marketplace platform, resulting in a year-over-year decrease in total revenues for second quarter 2019.

On this news, the Companys share price fell $1.21, or nearly 11%, to close at $9.39 per share on August 22, 2019. Yunjis share price continued to decline by $3.34, or over 35%, over the next three consecutive trading sessions to close at $6.05 per share on August 27, 2019.

By the time this class action was filed, Yunjis shares were trading as low as $4.40 per share, a nearly 60% decline from the $11 per share IPO price.

The complaint, filed on November 12, 2019, alleges that the Registration Statement was false and misleading and omitted to state material adverse facts. Specifically, Defendants failed to disclose to investors: (1) that the Company was shifting certain of its sales to its marketplace platform; (2) that this supply chain restructuring was likely to disrupt Yunjis relationships with suppliers; (3) that this supply chain restructuring was likely to have an adverse impact on the Companys financial results; and (4) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Yunji class action go to: https://bespc.com/yj

Plantronics, Inc. (NYSE: PLT)

Class Period: July 2, 2018 to November 5, 2019

Lead Plaintiff Deadline: January 13, 2020

On November 5, 2019, the Company disclosed a $65 million reduction in channel inventory by reducing sales to channel partners and decreased its fiscal 2020 guidance, expecting revenue between $1.72 billion and $1.81 billion and adjusted EBITDA between $282 million and $323 million. Plantronics also reported that its Executive Vice President of Global Sales was leaving the Company.

On this news, the Companys stock price fell $14.44 per share, or nearly 37%, to close at $25.00 per share on November 6, 2019.

The complaint, filed on November 13, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; (3) that the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Plantronics class action go to: https://bespc.com/plt

Lipocine, Inc. (NASDAQ: LPCN)

Class Period: March 27, 23019 to November 8, 2019

Lead Plaintiff Deadline: January 14, 2020

Lipocines lead product candidate is TLANDO (LPCN 1021), an oral testosterone replacement therapy. The Company has previously submitted New Drug Applications (NDA) for TLANDO twice and, both times, received Complete Response Letters (CRL) from the U.S. Food and Drug Administration (FDA) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018.

On March 27, 2019, Lipocine issued a press release announcing new topline results from a study evaluating TLANDOs effects on blood pressure (one issue cited by the FDA in a prior CRL rejecting TLANDOs NDA), as well as the Companys intention to refile the NDA for TLANDO in the second quarter of 2019.

On November 11, 2019, Lipocine issued a press release announcing receipt of a CRL from the FDA regarding its NDA for TLANDO. In the press release, Lipocine advised investors that the FDA had again rejected the NDA for TLANDOthis time because an efficacy trial had not met three of its secondary endpoints.

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

The Complaint, filed on November 14, 2019, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Companys business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the results from Lipocines clinical studies of TLANDO were insufficient to demonstrate the drugs efficacy; (ii) accordingly, Lipocines third NDA for TLANDO was highly likely to be found deficient by the FDA; and (iii) as a result, the Companys public statements were materially false and misleading at all relevant times.

For more information on the Lipocine class action go to: https://bespc.com/lpcn

Armstrong Flooring, Inc. (NYSE: AFI)

Class Period: March 6, 2018 to November 4, 2019

Lead Plaintiff Deadline: January 14, 2020

On May 3, 2019, Armstrong Floorings Chief Executive Officer abruptly resigned.

On this news, the Companys stock price fell $1.75, nearly 12%, to close at $13.14 per share on May 3, 2019.

Then, on November 5, 2019, Armstrong Flooring reported $165.6 million net sales for third quarter 2019, a nearly 21% decline year-over-year, and a net loss of $31.4 million. The Company also cut its full year 2019 guidance for adjusted EBITDA to a range of $20 million to $25 million, from prior guidance range of $46 million to $54 million, citing larger distributor movements on inventory than anticipated.

On this news, the Companys stock price fell $2.90 per share, or nearly 44%, to close at $3.70 per share on November 5, 2019.

The complaint, filed on November 15, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; and (3) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Armstrong Flooring class action go to: https://bespc.com/afi

About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit http://www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

See more here:
Bragar Eagel & Squire, PC Reminds Investors That Class Action Lawsuits Have Been Filed Against Yunji, Plantronics, Lipocine, and Armstrong...

Testosterone Replacement Therapy Market: Business Growth, Development Factors, Applications, and Future Prospects – Downey Magazine

Posted on December 2, 2019 by Prof Baldwin

In a recent report by Transparency Market Research, it is shown that the globaltestosterone replacement therapy marketis expected to grow negatively in the forecast period of 2016 to 2024. This adverse growth of the market is the result of various bans on the use of testosterones by various governments across the globe. Moreover, stringent regulations are also forcing company back-outs from the global testosterone replacement therapy market. This is also adding to the negative growth of the market.

Request Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097

According to the report, the global testosterone replacement therapy market is predominantly consolidated. This is because majority of the dynamics of the market is dominated by AbbVie, INC. a U.S. based pharmaceutical company that specializes in testosterone replacement therapy drugs. This dominance by the company and overall sluggish growth is making the new players entry quite difficult in testosterone replacement therapy market.

These players are looking forward to adopt various strategies such as mergers, collaborations, and partnerships in order to have a stable future in the global crop maintenance robots market. These strategies are providing the businesses with required resources to compete against the well established players of the market.

Whereas, AbbVie, INC. is launching new products in order to maintain its dominance in the global testosterone replacement therapy drugs market. Recently, the company had applied for approval of its cream product that can be used externally for testosterone replacement therapy.

According to various research and studies, the number of hypogonadism has risen substantially over couple of decades. This growth of the condition is showing some signs of growth in global testosterone replacement therapy market. Rising geriatric population is another minor factor that is expected to show growth possibilities in global testosterone replacement therapy market. Furthermore, various campaigns to educate people about the benefits of testosterone is also helping the global testosterone replacement therapy market to grow slowly in recent times.

Geriatric population in countries such as U.S. and Canada is one of the major reasons that are supporting North America to dominate the regions of global testosterone replacement therapy market. The growth of the region is also attributed to the presence of various key players of global testosterone replacement therapy market.

The article is listed by Transparency Market Research titled Testosterone Replacement Therapy Market (Product Creams/Gels, Patches, Injections, Gums/Buccal Adhesives, Implants; Active Ingredient Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 2024.

Read the original:
Testosterone Replacement Therapy Market: Business Growth, Development Factors, Applications, and Future Prospects - Downey Magazine

Testosterone Replacement Therapy Market Forecast Report by Market Insights, Volume, Opportunities, Type, Product Analysis, and Application – Exponent…

Posted on December 2, 2019 by Prof Baldwin

Testosterone Replacement Therapy Market report offers detailed analysis and a five-year forecast for the global Testosterone Replacement Therapy industry. Testosterone Replacement Therapy market report delivers the insights which will shape your strategic planning as you estimate geographic, product or service expansion within the Testosterone Replacement Therapy industry.. The Testosterone Replacement Therapy market is expected to grow at a CAGR of over XX% during the period 20192024.

The global Testosterone Replacement Therapy market has been subjected to several regulatory compliances and crucial coding terminology over the years. Adherence to regulatory standards remains crucial for vendors.

The study considers the present scenario of the Testosterone Replacement Therapy market and its market dynamics for the period 20192024. It covers a detailed overview of several market growth enablers, restraints, and trends. The report covers both the demand and supply aspect of the market. This research report on the Testosterone Replacement Therapy market covers sizing and forecast, market share, industry trends, growth drivers, and vendor analysis.

Read Report Details at https://www.proaxivereports.com/59211

The competitive environment in the Testosterone Replacement Therapy market is intensifying. The market currently witnesses the presence of several major as well as other prominent vendors, contributing toward the market growth. However, the market is observing an influx of local vendors entering the market.

The study profiles and examines leading companies and other prominent companies operating in the Testosterone Replacement Therapy industry.

List of key players profiled in the report:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Request for Sample Report athttps://www.proaxivereports.com/request-sample/59211

TheTestosterone Replacement TherapyMarket Segmentation:

Product Type SegmentationGelsInjectionsPatchesIndustry SegmentationHospitalsClinicsChannel (Direct Sales, Distributor) Segmentation

Vendors can consider targeting key regions such as APAC, North America, and Europe to gather maximum customer attention. Countries in the APAC region such as China, India, and Japan among others are expected to display significant growth prospects in the future due to high economic growth forecasts along with huge population statistics leading to high consumption of goods and products.

Ask more details or request custom reports to our experts athttps://www.proaxivereports.com/pre-order/59211

Testosterone Replacement Therapy Market segmentation by region:

The changing regulatory compliance scenario and the growing purchasing power among consumers are likely to promise well for the North America market. New product development and technological advancements remain key for competitors to capitalize upon in the Testosterone Replacement Therapy industry across the globe.

Purchase Testosterone Replacement Therapy Market Report athttps://www.proaxivereports.com/checkout/59211

Key Market Insights:

The report provides the following insights into the Testosterone Replacement Therapy market for the forecast period 20192024.

Excerpt from:
Testosterone Replacement Therapy Market Forecast Report by Market Insights, Volume, Opportunities, Type, Product Analysis, and Application - Exponent...

Dont Be Fooled: The Difference Between Testosterone …

Posted on December 24, 2017 by Prof Baldwin

Testosterone Booster vs. Replacement

Testosterone, while mostly thought of as the hormone that makes a male a man, there is more to its functions in the body. Testosterone is not only primarily responsible for the sex drive, it is also important for mans vitality, strength, agility and vigor. It is also important to women because it plays an intrinsic role in keeping them sexually active.

Summarily, it is often referred to as the elixir of youth, thanks to its ability to keep men feeling young and agile. Unfortunately, once you it the big 30, your testosterone levels start to decrease. This decline often results in depression, low libido, erectile dysfunction, difficulty in achieving orgasms, low ejaculation volume, impaired memory and poor concentration.

The combination of all these conditions is called hypogonadism. When this happens for a prolonged period of time and they are diagnosed with the LOW-T condition, most men start looking for solutions in the form of testosterone boosters and replacement therapy. Which brings us to the important question: Whats the difference between testosterone replacement therapy and testosterone boosters?

This is important because there is a clear difference between the two even though many often use the terms interchangeably.

Simply put, testosterone boosters are supplements that are used to help bodybuilders build more mass and strength. Also known as an alternative to anabolic steroids, this is nowhere near the real deal. T-Boosters as they are popularly called, are meant to help you do more and achieve more results whilst working out and training. Think of it as a steroid of sorts.

Only this time, its uncharted waters as evidenced by the lack of approval by the FDA. There are no known proofs of it being able to help boost your testosterone levels apart from the usual testosterone boost you get from high intensity workouts- no matter how much thats used in the products sales copies. All reports about testosterone boosters being able to help increase motivation seems unfounded and lacking in authenticity.

On the other hand, testosterone therapy is known for its effectiveness at boosting and increasing the testosterone levels of people who are suffering from hypogonadism. Its often known to help them become more agile, more enthusiastic, increases, their sense of well-being and sex drive, whilst eliminating problems like erectile dysfunction, depression, fatigue and poor concentration. There are quite a few testosterone replacement therapies.

Usually, talking to your doctor about how you feel will help them decide on what therapy method would best suit you. Many patients have recorded tremendous improvements on their testosterone levels through the impact of exogenous testosterone treatment regimens. Testosterone replacement therapies often include the use of testosterone patches, testosterone, topical gels and testosterone injections.

Men who have used testosterone gels often notice an increase in their testosterone levels to about 500-600 ng/dl (the normal testosterone levels) as against the 300 ng/dl levels observed in men diagnosed with Low-T. While there are testosterone pills, their use is largely discouraged because of their significant impact in liver toxicity.

Testosterone patches can be either scrotal or non-scrotal and are also known to be effective in increasing the bodys T-levels. The downside to using this however is that it tends to irritate the skin. Testosterone gels are known to be significantly absorbed by the skin and have a near-instant absorption rate which lasts throughout the day. And theres also the buccal testosterone which is known to produce even better results than the patches when applied to the gums. The side effects of that however often include bitter taste in the mouth and some irritation to the gums.

As you can see, testosterone boosters are clearly not the same thing as testosterone replacement. So, if you feel that you be might suffering from Low-T, consult with your doctors and let them place you on the necessary testosterone replacement therapies instead of self-medicating with testosterone boosters.

Sources:

http://www.harvardprostateknowledge.org/a-harvard-expert-shares-his-thoughts-on-testosterone-replacement-therapy

http://www.webmd.com/erectile-dysfunction/guide/testosterone-replacement-therapy

http://www.health.harvard.edu/press_releases/is-testosterone-replacement-therapy-safe

http://www.webmd.com/men/guide/testosterone-replacement-therapy-is-it-right-for-you0

Here is the original post:
Dont Be Fooled: The Difference Between Testosterone ...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yunji, Plantronics, Lipocine, and Armstrong…

Posted on November 29, 2019 by Prof Baldwin

NEW YORK, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Yunji, Inc. (YJ), Plantronics, Inc. (PLT), Lipocine, Inc. (LPCN), and Armstrong Flooring, Inc (AFI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Yunji, Inc. (YJ)

Lead Plaintiff Deadline: January 13, 2020

On May 3, 2019, the Company held its IPO in which it sold 11,217,447 shares for $11.00 per share.

By the time this class action was filed, Yunjis shares were trading as low as $4.40 per share, a nearly 60% decline from the $11 per share IPO price.

For more information on the Yunji class action go to: https://bespc.com/yj

Plantronics, Inc. (PLT)

Class Period: July 2, 2018 to November 5, 2019

Lead Plaintiff Deadline: January 13, 2020

On this news, the Companys stock price fell $14.44 per share, or nearly 37%, to close at $25.00 per share on November 6, 2019.

For more information on the Plantronics class action go to: https://bespc.com/plt

Lipocine, Inc. (LPCN)

Class Period: March 27, 23019 to November 8, 2019

Lead Plaintiff Deadline: January 14, 2020

Story continues

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

For more information on the Lipocine class action go to: https://bespc.com/lpcn

Armstrong Flooring, Inc. (AFI)

Class Period: March 6, 2018 to November 4, 2019

Lead Plaintiff Deadline: January 14, 2020

On May 3, 2019, Armstrong Floorings Chief Executive Officer abruptly resigned.

On this news, the Companys stock price fell $1.75, nearly 12%, to close at $13.14 per share on May 3, 2019.

On this news, the Companys stock price fell $2.90 per share, or nearly 44%, to close at $3.70 per share on November 5, 2019.

For more information on the Armstrong Flooring class action go to: https://bespc.com/afi

Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

best testosterone replacement therapy | Find the best testosterone replacement therapy – Video

Posted on January 30, 2015 by Prof Baldwin

best testosterone replacement therapy | Find the best testosterone replacement therapy
best testosterone replacement therapy | Find the best testosterone replacement therapy What exactly is Testosterone Replacement Therapy? A progressively more Well-known Phrase Although many...

By: best testosterone replacement therapy

See the article here:
best testosterone replacement therapy | Find the best testosterone replacement therapy - Video

The LIFE*MOD Podcast With Dr. Gonzalez – Testosterone Replacement Therapy Part 1 – Video

Posted on February 13, 2015 by Prof Baldwin

The LIFE*MOD Podcast With Dr. Gonzalez - Testosterone Replacement Therapy Part 1
In this weeks episode Dr. Gonzalez and Andrew discuss Testosterone Replacement for men. Andrew recently discovered that his Testosterone levels were a little...

By: Life*Mod - premiere lifestyle modification

See more here:
The LIFE*MOD Podcast With Dr. Gonzalez - Testosterone Replacement Therapy Part 1 - Video

Testosterone Replacement Therapy Side Effects – Video

Posted on September 17, 2014 by Prof Baldwin

Testosterone Replacement Therapy Side Effects
Michael Blom, a personal injury lawyer at the NYC-based national pharmaceutical litigation firm Levy Konigsberg LLP, discusses legal rights of men who may have suffered such side effects of...

By: Levy Konigsberg LLP

More here:
Testosterone Replacement Therapy Side Effects - Video

Why I’m CHANGING UP My Testosterone Replacement Therapy! – Video

Posted on October 10, 2014 by Prof Baldwin

Why I #39;m CHANGING UP My Testosterone Replacement Therapy!
After 2 1/2 years on TRT I am finally going to change on my protocol based on recent blood work and some potential side effects that I have not been addressing. My previous regiment was 200mg...

By: bignoknow

See more here:
Why I'm CHANGING UP My Testosterone Replacement Therapy! - Video

natural testosterone replacement , natural testosterone therapy , natural testosterone supplements – Video

Posted on May 2, 2015 by Prof Baldwin

natural testosterone replacement , natural testosterone therapy , natural testosterone supplements
http://www.lnk123.com/SHLu0 Pro Testosterone is backed by proven herbal science with research to back it up. This has combined to create a completely natural supplement than can help...

By: Vale Elaw

Testosterone therapy: Potential benefits and risks as you …

Posted on May 19, 2015 by Prof Baldwin

Testosterone therapy: Potential benefits and risks as you age

Considering testosterone therapy to help you feel younger and more vigorous as you age? Know the risks before you make your decision.

The promise of testosterone therapy may seem enticing, but there are a lot of misconceptions about what the treatment can and can't do for you. As you get older, testosterone therapy may sound like the ultimate anti-aging formula.

Yet the health benefits of testosterone therapy for age-related decline in testosterone aren't as clear as they may seem. Find out what's known and not known about testosterone therapy for normal aging.

Testosterone is a hormone produced primarily in the testicles. Testosterone helps maintain men's:

Testosterone levels generally peak during adolescence and early adulthood. As you get older, your testosterone level gradually declines typically about 1 percent a year after age 30 or 40. It is important to determine in older men if a low testosterone level is simply due to the decline of normal aging or if it is due to a disease (hypogonadism).

Hypogonadism is a disease in which the body is unable to produce normal amounts of testosterone due to a problem with the testicles or with the pituitary gland that controls the testicles. Testosterone replacement therapy can improve the signs and symptoms of low testosterone in these men. Doctors may prescribe testosterone as injections, pellets, patches or gels.

Not necessarily. Men can experience many signs and symptoms as they age. Some may occur as a result of lower testosterone levels and can include:

Some of these signs and symptoms can be caused by various underlying factors, including medication side effects, obstructive sleep apnea, thyroid problems, diabetes and depression. It's also possible that these conditions may be the cause of low testosterone levels, and treatment of these problems may cause testosterone levels to rise. A blood test is the only way to diagnose a low testosterone level.

Continue reading here:
Testosterone therapy: Potential benefits and risks as you ...

Erectile Dysfunction and Testosterone Replacement Therapy

Posted on October 12, 2017 by Prof Baldwin

Testosterone is a hormone produced by the testicles and is responsible for the proper development of male sexual characteristics. Testosterone is also important for maintaining muscle bulk, adequate levels of red blood cells, bone growth, a sense of well-being, and sexual function.

Inadequate production of testosterone is not a common cause of erectile dysfunction; however, when ED does occur due to decreased testosterone production, testosterone replacement therapy may improve the problem.

As a man ages, the amount of testosterone in his body naturally gradually declines. This decline starts after age 30 and continues throughout life. Some causes of low testosterone levels are due to:

Without adequate testosterone, a man may lose his sex drive, experience erectile dysfunction, feel depressed, have a decreased sense of well-being, and have difficulty concentrating.

Low testosterone can cause the following physical changes:

The only accurate way to detect the condition is to have your doctor measure the amount of testosterone in your blood. Because testosterone levels fluctuate throughout the day, several measurements will need to be taken to detect a deficiency. Doctors prefer, if possible, to test levels early in the morning, when testosterone levels are highest.

Note: Testosterone should only be used by men who have clinical signs and symptoms AND medically documented low testosterone levels.

Testosterone deficiency can be treated by:

Each of these options provides adequate levels of hormone replacement; however, they all have different advantages and disadvantages. Talk to your doctor to see which approach is right for you.

Men who have prostate cancer or breast cancer should not take testosterone replacement therapy. Nor should men who have severe urinary tract problems, untreated severe sleep apnea or uncontrolled heart failure. All men considering testosterone replacement therapy should undergo a thorough prostate cancer screening -- a rectal exam and PSA test -- prior to starting this therapy.

In general, testosterone replacement therapy is safe. It is associated with some side effects, including:

Laboratory abnormalities that can occur with hormone replacement include:

If you are taking hormone replacement therapy, regular follow-up appointments with your doctor are important.

Like any other medication, directions for administering testosterone should be followed exactly as your doctor orders. If you are unsure or have any questions about testosterone replacement therapy, ask your doctor.

SOURCE:

Get-Back-On-Track.com.

The Hormone Foundation.

News release, FDA.

Original post:
Erectile Dysfunction and Testosterone Replacement Therapy

Testosterone Replacement & Potassium | Healthfully

Posted on May 28, 2019 by Prof Baldwin

Potassium and testosterone levels play a key role in how your body develops. Low testosterone levels could lead to testosterone replacement therapy. These treatments may benefit you, but care should be taken to evaluate lab results for other abnormalities. According to the Cleveland Clinic, these may include a change in potassium levels, red blood cells, cholesterol concentrations, or a decrease in sperm count.

Male sexual characteristics are dependent upon the production of testosterone from the testicles. Muscle bulk and bone density are features that are influenced by the amount of testosterone. According to the Cleveland Clinic, testosterone is also important in keeping a sense of well being. If you have a low sense of well-being, lethargy, low libido, erectile dysfunction, or are feeling depressed, you may be having symptoms of low testosterone. If this is true, you may benefit from testosterone replacement therapy.

Testosterone replacement therapy can be prescribed by your doctor after he has confirmed your low testosterone levels. The testosterone hormone can be given by intramuscular injections, body or scrotum patches, and also in a gel form that can be rubbed into the body. Your doctor will know which therapy treatment would be best for you. The Testosterone Report states that care should be taken if you are using the patches or gels to assure that your partner or another individual does not come into contact with the product. This could cause an increase in testosterone levels and create unwanted side effects.

Potassium helps with the conduction of electricity throughout your body. This electrolyte functionality is crucial in helping the muscles in your heart and body to contract, according to the University of Maryland Medical Center. It is important to have the correct amount of potassium in your blood levels to ensure that your cells function correctly. If you are having testosterone therapy treatments, you need to know that your potassium levels may be affected.

In a study published by "Neurology," individuals were given a 10 to 13 week testosterone therapy treatment with weekly injections of testosterone. That study showed that at the end of the treatments, their potassium levels rose by 16 percent. One of the side effects of testosterone therapy treatment is the retention of potassium. Due to this increase, you should discuss with your doctor whether you should avoid high potassium foods or if any medication changes are needed.

Although there is a link to higher potassium levels with testosterone replacement therapy, more studies are needed to determine the significance of these findings. Your doctor will be able to decide if the risk of a high potassium level outweighs the risk of low testosterone. With lab tests and medications, your doctor should be able to keep a good balance between the two.

See the original post:
Testosterone Replacement & Potassium | Healthfully

Select Page ::